KSHV vIL-6 enhances inflammatory responses by epigenetic reprogramming
PLOS Pathogens · 2023
DOI: 10.1371/journal.ppat.1011771 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Tomoki Inagaki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, School of Medicine, the University of California Davis (UC Davis), Sacramento, California, United States of America. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Herpesviridae Infections, Sarcoma, Kaposi. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Kaposi sarcoma-associated herpesvirus (KSHV) inflammatory cytokine syndrome (KICS) is a newly described chronic inflammatory disease condition caused by KSHV infection and is characterized by high KSHV viral load and sustained elevations of serum KSHV-encoded IL-6 (vIL-6) and human IL-6 (hIL-6). KICS has significant immortality and greater risks of other complications, including malignancies. Although prolonged inflammatory vIL-6 exposure by persistent KSHV infection is expected to have key roles in subsequent disease development, the biological effects of prolonged vIL-6 exposure remain elusive. Using thiol(SH)-linked alkylation for the metabolic (SLAM) sequencing and Cleavage Under Target & Release Using Nuclease analysis (CUT&RUN), we studied the effect of prolonged vIL-6 exposure in chromatin landscape and resulting cytokine production. The studies showed that prolonged vIL-6 exposure increased Bromodomain containing 4 (BRD4) and histone H3 lysine 27 acetylation co-occupancies on chromatin, and the recruitment sites were frequently co-localized with poised RNA polymerase II with associated enzymes. Increased BRD4 recruitment on promoters was associated with increased and prolonged NF-κB p65 binding after the lipopolysaccharide stimulation. The p65 binding resulted in quicker and sustained transcription bursts from the promoters; this mechanism increased total amounts of hIL-6 and IL-10 in tissue culture. Pretreatment with the BRD4 inhibitors, OTX015 and MZ1, eliminated the enhanced inflammatory cytokine production. These findings suggest that persistent vIL-6 exposure may establish a chromatin landscape favorable for the reactivation of inflammatory responses in monocytes. This epigenetic memory may explain the greater risk of chronic inflammatory disease development in KSHV-infected individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, School of Medicine, the University of California Davis (UC Davis), Sacramento, California, United States of America.
- Department of Pathology and Laboratory Medicine, School of Medicine, UC Davis, Sacramento, California, United States of America.
- Department of Biochemistry and Molecular Medicine, School of Medicine, UC Davis, Sacramento, California, United States of America.
- Department of Pathology, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
ORCID-Profile: Tomoki Inagaki, Yoshihiro Izumiya
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- Comprehensive Cancer Center, University of California, Davis
Zitieren
APA
Inagaki, T., Wang, K. H., Kumar, A., Izumiya, C., Miura, H., Komaki, S., Davis, R. R., Tepper, C. G., Katano, H., Shimoda, M., & Izumiya, Y. (2023). KSHV vIL-6 enhances inflammatory responses by epigenetic reprogramming. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011771
Vancouver
Inagaki T, Wang KH, Kumar A, Izumiya C, Miura H, Komaki S, et al. KSHV vIL-6 enhances inflammatory responses by epigenetic reprogramming. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011771
BibTeX
@article{Inagaki2023,
author = {Inagaki, Tomoki and Wang, Kang-Hsin and Kumar, Ashish and Izumiya, Chie and Miura, Hiroki and Komaki, Somayeh and Davis, Ryan R and Tepper, Clifford G and Katano, Harutaka and Shimoda, Michiko and Izumiya, Yoshihiro},
title = {KSHV vIL-6 enhances inflammatory responses by epigenetic reprogramming},
journal = {PLOS Pathogens},
year = {2023},
doi = {10.1371/journal.ppat.1011771}
}
EUVIMED